SCHEMBL9564437

SCHEMBL9564437

CCN/C(=C\C(=O)c1c(C)cc(C)nc1C)SC

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.37
CYP1A2 P05177 2/20 0.36
SMN1; SMN2 Q16637 4/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 1/20 0.35
POLB P06746 2/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 4/20 0.32
LMNA P02545 3/20 0.32
CREBBP Q92793 1/20 0.32
CHRM4 P08173 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9564440 1.00 L3MBTL1 (0.37) L3MBTL1CYP1A2SMN1; SMN2ALDH1A1MAPK1
SCHEMBL9564345 0.70 KDR (0.34) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL9564349 0.70 KDR (0.34) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL9564365 0.69 KMT2A (0.43) L3MBTL1CYP1A2SMN1; SMN2ALDH1A1POLB
SCHEMBL9564372 0.69 KMT2A (0.43) L3MBTL1CYP1A2SMN1; SMN2ALDH1A1POLB
SCHEMBL9564366 0.68 GAA (0.50) CYP1A2SMN1; SMN2ALDH1A1MAPK1POLB
SCHEMBL9564371 0.68 GAA (0.50) CYP1A2SMN1; SMN2ALDH1A1MAPK1POLB
SCHEMBL9564356 0.68 KDM4E (0.42) ALDH1A1POLBMEN1KMT2AKDM4E
SCHEMBL27898719 0.67 SMN1; SMN2 (0.47) CYP1A2SMN1; SMN2ALDH1A1MAPK1POLB
SCHEMBL9564389 0.66 MAPT (0.49) SMN1; SMN2ALDH1A1MAPK1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0563686-A1 Utilization of 3 substituted amino isoxazole derivatives against endoparasites, new 3 substituted amino isoxazols and process for their preparation BAYER AG (DE) 1993-10-06 EP disclosed